Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Fiji Kava Limited ( (AU:CCO) ) has issued an update.
The Calmer Co. reported its second consecutive quarter of revenue above $2 million, posting $2.01 million in Q2 FY26, driven by strong omni-channel demand and a record December sales month of $910,000. While quarterly revenue fell 16% from Q1 due to an expected post-launch normalisation, U.S. sales rose 9% quarter-on-quarter to $1.01 million and now represent 51% of group revenue, underscoring the success of the company’s U.S. expansion and growing wholesale and B2B extract business. Net operating cash outflows widened to $757,000 largely due to targeted R&D on a new CO₂ extract format and increased marketing spend around new flavoured kava shots in the U.S., while inventory was deliberately built up to $1.77 million to support anticipated demand and staff costs were trimmed further as management pursues cost discipline on its path toward breakeven.
The most recent analyst rating on (AU:CCO) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Fiji Kava Limited stock, see the AU:CCO Stock Forecast page.
More about Fiji Kava Limited
The Calmer Co. International Limited (ASX: CCO), formerly Fiji Kava Limited, operates a diversified omni-channel business focused on kava-based products, selling through retail, e-commerce, wholesale and B2B extract channels, with a growing emphasis on the United States market.
Technical Sentiment Signal: Sell
Current Market Cap: A$15.29M
For detailed information about CCO stock, go to TipRanks’ Stock Analysis page.